That is also skillful distraction. You and all of us know that the issue was that the immune flare ups may have possibly been misdiagnosed as recurrence but, patients lived longer. We all know that the ability to diagnose this also has improved since the trial started. That does not mean they failed on PFS but they may have decided that it would make more sense ultimately to update their SAP later in the trial and to look to their long-tail, which they have been quite straightforward about since I have been actively around here.
But you take us back to a time warp to make your point as if it’s still relevant. It’s a nice trick.
News 
Market Data 
Discover 
